Gene Gene information from NCBI Gene database.
Entrez ID 80144
Gene name Fraser extracellular matrix complex subunit 1
Gene symbol FRAS1
Synonyms (NCBI Gene)
FRASRS1
Chromosome 4
Chromosome location 4q21.21
Summary This gene encodes an extracellular matrix protein that appears to function in the regulation of epidermal-basement membrane adhesion and organogenesis during development. Mutations in this gene cause Fraser syndrome, a multisystem malformation that can in
SNPs SNP information provided by dbSNP.
48
SNP ID Visualize variation Clinical significance Consequence
rs1872267 C>T Conflicting-interpretations-of-pathogenicity, uncertain-significance Coding sequence variant, missense variant
rs56291926 G>A,T Conflicting-interpretations-of-pathogenicity Stop gained, missense variant, coding sequence variant, genic downstream transcript variant
rs61729366 G>A Benign-likely-benign, uncertain-significance, risk-factor, benign Missense variant, coding sequence variant, genic downstream transcript variant
rs111554790 G>A Conflicting-interpretations-of-pathogenicity Missense variant, coding sequence variant
rs120074156 C>T Pathogenic Stop gained, coding sequence variant, genic downstream transcript variant
miRNA miRNA information provided by mirtarbase database.
301
miRTarBase ID miRNA Experiments Reference
MIRT022324 hsa-miR-124-3p Proteomics;Microarray 18668037
MIRT1004046 hsa-miR-1256 CLIP-seq
MIRT1004047 hsa-miR-1278 CLIP-seq
MIRT1004048 hsa-miR-193a-3p CLIP-seq
MIRT1004049 hsa-miR-193b CLIP-seq
Gene ontology (GO) Gene Ontology (GO) annotations describing the biological processes, molecular functions, and cellular components associated with a gene.
18
GO ID Ontology Definition Evidence Reference
GO:0002009 Process Morphogenesis of an epithelium IEA
GO:0003338 Process Metanephros morphogenesis IEA
GO:0005201 Function Extracellular matrix structural constituent ISS
GO:0005515 Function Protein binding IPI 33961781
GO:0005604 Component Basement membrane IEA
Other IDs Other IDs provides unique identifiers for this gene in OMIM, HGNC, and Ensembl databases.
MIM HGNC e!Ensembl
607830 19185 ENSG00000138759
Protein Protein information from UniProt database.
UniProt ID Unique identifier for the protein in the UniProt database. Click to view detailed protein information.
Q86XX4
Protein name Extracellular matrix organizing protein FRAS1 (Fraser syndrome 1 protein)
Protein function Involved in extracellular matrix organization (By similarity). Required for the regulation of epidermal-basement membrane adhesion responsible for proper organogenesis during embryonic development (By similarity). Involved in brain organization
Family and domains

Pfam

Accession ID Position in sequence Description Type
PF00093 VWC 95 152 von Willebrand factor type C domain Family
PF00093 VWC 159 216 von Willebrand factor type C domain Family
PF00093 VWC 221 278 von Willebrand factor type C domain Family
PF00093 VWC 285 342 von Willebrand factor type C domain Family
PF16184 Cadherin_3 1099 1199 Domain
PF16184 Cadherin_3 1203 1310 Domain
PF16184 Cadherin_3 1313 1439 Domain
PF16184 Cadherin_3 1446 1574 Domain
PF16184 Cadherin_3 1577 1691 Domain
PF16184 Cadherin_3 1694 1812 Domain
PF16184 Cadherin_3 1816 1938 Domain
PF16184 Cadherin_3 1941 2059 Domain
PF16184 Cadherin_3 2067 2179 Domain
PF16184 Cadherin_3 2184 2293 Domain
PF16184 Cadherin_3 2295 2406 Domain
PF16184 Cadherin_3 2422 2538 Domain
PF03160 Calx-beta 2547 2646 Calx-beta domain Domain
PF03160 Calx-beta 2659 2770 Calx-beta domain Domain
PF03160 Calx-beta 2784 2890 Calx-beta domain Domain
PF03160 Calx-beta 2903 3007 Calx-beta domain Domain
PF03160 Calx-beta 3025 3129 Calx-beta domain Domain
Tissue specificity TISSUE SPECIFICITY: Expressed in many adult tissues, with highest levels in kidney, pancreas and thalamus. Relatively high expression was also detected in fetal kidney and heart. {ECO:0000269|PubMed:12766769}.
Sequence
MGVLKVWLGLALALAEFAVLPHHSEGACVYQDSLLADATIWKPDSCQSCRCHGDIVICKP
AVCRNPQCAFEKGEVLQIAANQCCPECVLRTPGSCHHEKKIHEHGTEWASSPCSVCSCNH
GEVRCTPQPCPPLSCGHQELAFIPEGSCCPVC
VGLGKPCSYEGHVFQDGEDWRLSRCAKC
LCRNGVAQCFTAQCQPLFCNQDETVVRVPGKCCPQC
SARSCSAAGQVYEHGEQWSENACT
TCICDRGEVRCHKQACLPLRCGKGQSRARRHGQCCEEC
VSPAGSCSYDGVVRYQDEMWKG
SACEFCMCDHGQVTCQTGECAKVECARDEELIHLDGKCCPEC
ISRNGYCVYEETGEFMSS
NASEVKRIPEGEKWEDGPCKVCECRGAQVTCYEPSCPPCPVGTLALEVKGQCCPDCTSVH
CHPDCLTCSQSPDHCDLCQDPTKLLQNGWCVHSCGLGFYQAGSLCLACQPQCSTCTSGLE
CSSCQPPLLMRHGQCVPTCGDGFYQDRHSCAVCHESCAGCWGPTEKHCLACRDPLHVLRD
GGCESSCGKGFYNRQGTCSACDQSCDSCGPSSPRCLTCTEKTVLHDGKCMSECPGGYYAD
ATGRCKVCHNSCASCSGPTPSHCTACSPPKALRQGHCLPRCGEGFYSDHGVCKACHSSCL
ACMGPAPSHCTGCKKPEEGLQVEQLSDVGIPSGECLAQCRAHFYLESTGICEACHQSCFR
CAGKSPHNCTDCGPSHVLLDGQCLSQCPDGYFHQEGSCTECHPTCRQCHGPLESDCISCY
PHISLTNGNCRTSCREEQFLNLVGYCADCHHLCQHCAADLHNTGSICLRCQNAHYLLLGD
HCVPDCPSGYYAERGACKKCHSSCRTCQGRGPFSCSSCDTNLVLSHTGTCSTTCFPGHYL
DDNHVCQPCNTHCGSCDSQASCTSCRDPNKVLLFGECQYESCAPQYYLDFSTNTCKECDW
SCSACSGPLKTDCLQCMDGYVLQDGACVEQCLSSFYQDSGLCKNCDSYCLQCQGPHECTR
CKGPFLLLEAQCVQECGKGYFADHAKHKCTACPQGCLQCSHRDRCHLCDHGFFLKSGLCV
YNCVPGFSVHTSNETCSGKIHTPSLHVNGSLILPIGSIKPLDFSLLNVQDQEGRVEDLLF
HVVSTPTNGQLVLSRNGKEVQLDKAGRFSWKDVNEKKVRFVHSKEKLRKGYLFLKISDQ
Q
FFSEPQLINIQAFSTQAPYVLRNEVLHISRGERATITTQMLDIRDDDNPQDVVIEIIDPP
LHGQLLQTLQSPATPIYQFQLDELSRGLLHYAHDGSDSTSDVAVLQANDG
HSFHNILFQV
KTVPQNDRGLQLVANSMVWVPEGGMLQITNRILQAEAPGASAEEIIYKITQDYPQFGEVV
LLVNMPADSPADEGQHLPDGRTATPTSTFTQQDINEGIVWYRHSGAPAQSDSFRFEVSS
A
SNAQTRLESHMFNIAILPQTPEAPKVSLEASLHMTAREDGLTVIQPHSLSFINSEKPSGK
IVYNITLPLHPNQGIIEHRDHPHSPIRYFTQEDINQGKVMYRPPPAAPHLQELMAFSFAG
LPESVKFHFTVSDG
EHTSPEMVLTIHLLPSDQQLPVFQVTAPRLAVSPGGSTSVGLQVVV
RDAETAPKELFFELRRPPQHGVLLKHTAEFRRPMATGDTFTYEDVEKNALQYIHDGSSTR
EDSMEISVTDG
LTVTMLEVRVEVSLSEDRGPRLAAGSSLSITVASKSTAIITRSHLAYVD
DSSPDPEIWIQLNYLPSYGTLLRISGSEVEELSEVSNFTMEDINNKKIRYSAVFETDGHL
VTDSFYFSVSDM
DHNHLDNQIFTIMITPAENPPPVIAFADLITVDEGGRAPLSFHHFFAT
DDDDNLQRDAIIKLSALPKYGCIENTGTGDRFGPETASDLEASFPIQDVLENYIYYFQSV
HESIEPTHDIFSFYVSDG
TSRSEIHSINITIERKNDEPPRMTLQPLRVQLSSGVVISNSS
LSLQDLDTPDNELIFVLTKKPDHGHVLWRQTASEPLENGRVLVQGSTFTYQDILAGLVGY
VPSVPGMVVDEFQFSLTDG
LHVDTGRMKIYTELPASDTPHLAINQGLQLSAGSVARITEQ
HLKVTDIDSDDHQVMYIMKEDPGAGRLQMMKHGNLEQISIKGPIRSFTQADISQGQPEYS
HGTGEPGGSFAFKFDVVDG
EGNRLIDKSFSISISEDKSPPVITTNKGLVLDENSVKKITT
LQLSATDQDSGPTELIYRITRQPQLGHLEHAASPGIQISSFTQADLTSRNVQYVHSSEAE
KHSDAFSFTLSDG
VSEVTQTFHITLHPVDDSLPVVQNLGMRVQEGMRKTITEFELKAVDA
DTEAESVTFTIVQPPRHGTIERTSNGQHFHLTSTFTMKDIYQNRVSYSHDGSNSLKDRFT
FTVSDG
TNPFFIIEEGGKEIMTAAPQPFRVDILPVDDGTPRIVTNLGLQWLEYMDGKATN
LITKKELLTMDPDTEDAQLVYEITTGPKHGFVENKLQPGRAAATFTQEDVNLGLIRYVLH
KEKIREMMDSFQFLVKDS
KPNVVSDNVFHIQWSLISFKYTSYNVSEKAGSVSVTVQRTGN
LNQYAIVLCRTEQGTASSSSQPGQQDYVEYAGQVQFDEREDTKSCTIVINDDDVFENVES
FTVELS
MPAYALLGEFTQAKVIINDTEDEPTLEFDKKIYWVNESAGFLFAPIERKGDASS
IVSAICYTVPKSAMGSLFYALESGSDFKSRGMSAASRVIFGPGVTMSTCDVMLIDDSEYE
EEEEFEIALA
DASDNARIGRVATAKVLISGPNDASTVSLGNTAFTVSEDAGTVKIPVIRH
GTDLSTFASVWCATRPSDPASATPGVDYVPSSRKVEFGPGVIEQYCTLTILDDTQYPVIE
GLETFVVFLS
SAQGAELTKPFQAVIAINDTFQDVPSMQFAKDLLLVKEKEGVLHVPITRS
GDLSYESSVRCYTQSHSAQVMEDFEERQNADSSRITFLKGDKVKNCTVYIHDDSMFEPEE
QFRVYLG
LPLGNHWSGARIGKNNMATITISNDEDAPTIEFEEAAYQVREPAGPDAIAILN
IKVIRRGDQNRTSKVRCSTRDGSAQSGVDYYPKSRVLKFSPGVDHIFFKVEILSNEDREW
HESFSLVLG
PDDPVEAVLGDVTTATVTILDQEAAGSLILPAPPIVVTLADYDHVEEVTKE
GVKKSPSPGYPLVCVTPCDPHFPRYAVMKERCSEAGINQTSVQFSWEVAAPTDGNGARSP
FETITDNTPFTSVNHMVLDSIYFSRRFHVRCVAKAVDKVGHVGTPLRSNIVTIGTDSAIC
HTPVVAGTSRGFQAQSFIATLKYLDVKHKEHPNRIHISVQIPHQDGMLPLISTMPLHNLH
FLLSESIYRHQHVCSNLVTTYDLRGLAEAGFLDDVVYDSTALGPGYDRPFQFDPSVREPK
TIQLYKHLNLKSCVWTFDAYYDMTELIDVCGGSVTADFQVRDSAQSFLTVHVPLYVSYIY
VTAPRGWASLEHHTEMEFSFFYDTVLWRTGIQTDSVLSARLQIIRIYIREDGRLVIEFKT
HAKFRGQFVMEHHTLPEVKSFVLTPDHLGGIEFDLQLLWSAQTFDSPHQLWRATSSYNRK
DYSGEYTIYLIPCTVQPTQPWVDPGEKPLACTAHAPERFLIPIAFQQTNRPVPVVYSLNT
EFQLCNNEKVFLMDPNTSDMSLAEMDYKGAFSKGQILYGRVLWNPEQNLNSAYKLQLEKV
YLCTGKDGYVPFFDPTGTIYNEGPQYGCIQPNKHLKHRFLLLDRNQPEVTDKYFHDVPFE
AHFASELPDFHVVSNMPGVDGFTLKVDALYKVEAGHQWYLQVIYIIGPDTISGPRVQRSL
TAPLRRNRRDLVEPDGQLILDDSLIYDNEGDQVKNGTNMKSLNLEMQELAVAASLSQTGA
SIGSALAAIMLLLLVFLVACFINRKCQKQRKKKPAEDILEEYPLNTKVEVPKRHPDRVEK
NVNRHYCTVRNVNILSEPEAAYTFKGAKVKRLNLEVRVHNNLQDGTEV
Sequence length 4008
Interactions View interactions
Pathways Pathway information has different metabolic/signaling pathways associated with genes.
  KEGG 
  ECM-receptor interaction  
Associated diseases Disease associations from ClinVar categorized as Causal (Pathogenic/Likely Pathogenic) or Unknown.
1135
Causal Diseases associated with Pathogenic or Likely Pathogenic variants in ClinVar
Phenotype Name Clinical Significance dbSNP ID RCV Accession
Congenital anomaly of kidney and urinary tract Likely pathogenic; Pathogenic rs773232259, rs745597204, rs200282443 RCV001849615
RCV001328302
RCV001328204
Cryptophthalmos syndrome Likely pathogenic; Pathogenic rs753831692 RCV005367737
FRAS1-related disorder Pathogenic; Likely pathogenic rs377046630, rs902819798, rs2475851664, rs2477269322, rs1727393873, rs751167632, rs1718846418, rs776570778 RCV003407662
RCV003418573
RCV003402529
RCV003416818
RCV003419024
RCV003420761
RCV004723366
RCV004741674
Fraser syndrome 1 Likely pathogenic; Pathogenic rs753263924, rs756005814, rs1731436153, rs1578330963, rs1460031293, rs1560604726, rs2109847651, rs1263546070, rs776789412, rs201947516, rs2110296712, rs936338537, rs2110325478, rs2109834757, rs1718842724
View all (88 more)
RCV001645007
RCV001645008
RCV001330026
RCV001376187
RCV001780361
RCV001536002
RCV001535834
RCV001535980
RCV005038268
RCV005040343
RCV001783311
RCV001781130
RCV001807682
RCV001807683
RCV001807684
RCV001806447
RCV001837046
RCV002489897
RCV005419301
RCV002284041
RCV000002943
RCV000002944
RCV000002946
RCV000002947
RCV000002948
RCV000002949
RCV000002950
RCV002470130
RCV002500475
RCV001172426
RCV001172407
RCV003138369
RCV000257997
RCV000257971
RCV002485447
RCV000778741
RCV003145709
RCV003148076
RCV003153167
RCV003226852
RCV003226853
RCV003226855
RCV003387496
RCV005036781
RCV003486316
RCV005036845
RCV005047663
RCV005220748
RCV005433417
RCV004594703
RCV005036912
RCV005047724
RCV005036954
RCV005047797
RCV005036957
RCV005036963
RCV005036991
RCV005037006
RCV005040534
RCV005038546
RCV005637076
RCV005040554
RCV005038544
RCV003986021
RCV000500822
RCV001330027
RCV000761280
RCV000768557
RCV000782142
RCV000782358
RCV000782359
RCV000790410
RCV001172405
RCV001172411
RCV001172414
RCV001172419
RCV001172416
RCV001172424
RCV001172412
RCV001172429
RCV001172408
RCV001172430
RCV001172415
RCV001172423
RCV001172427
RCV001172432
RCV001172434
RCV001172433
RCV001172431
RCV001172436
RCV001172439
RCV001172410
RCV001172425
RCV001172413
RCV001172421
RCV001172435
RCV001172428
RCV001172406
RCV001172438
RCV001172420
RCV001172440
RCV001376125
RCV001283840
RCV001283829
RCV001293651
Unknown Diseases with uncertain, conflicting, or no pathogenic evidence in ClinVar
Phenotype Name Clinical Significance dbSNP ID RCV Accession
Anophthalmia-microphthalmia syndrome Conflicting classifications of pathogenicity rs200346497 RCV000207380
Cervical cancer Benign; Likely benign rs78711748, rs113324102, rs61999335, rs112081709, rs17003335, rs773904548 RCV005897870
RCV005897895
RCV005897878
RCV005897887
RCV005897898
RCV005934857
Clear cell carcinoma of kidney Likely benign; Benign; Conflicting classifications of pathogenicity rs2477143244, rs61999335, rs74510691, rs370018000 RCV005931636
RCV005897880
RCV005897894
RCV005910797
Colon adenocarcinoma Benign rs61999335 RCV005897876
Associations from Text MiningDisease associations identified through Pubtator
Disease Name Relationship Type References
Alzheimer Disease Associate 35139885
Breast Neoplasms Associate 28027327
Cakut Associate 21900877
Cardiomyopathies Associate 33719213
Cardiomyopathy Dilated Associate 33719213
Cardiomyopathy Dilated with Left Ventricular Noncompaction Associate 33719213
CHARGE Syndrome Associate 33719213
Fraser Syndrome Associate 21900877, 33719213, 35181022, 35595450
Glomerulonephritis Membranous Associate 37974210
Hypogonadism Associate 33719213